Latest Oncology Stories
- Note: This press release corresponds to abstracts 4453 and 4471 SAN FRANCISCO, Dec.
MileOne Automotive donated a car to the American Cancer Society for their 15th year in a row, which was raffled off and raised over $75,000. Baltimore, MD (PRWEB)
IMBRUVICA data presented at the American Society of Hematology Annual Meeting show 79 percent of CLL patients with del 17p were progression-free at 12 months SAN FRANCISCO and RARITAN, N.J.,
Data Show 84% Progression-Free Survival Rate at One Year and Improvement in Quality of Life SAN FRANCISCO, Dec. 8, 2014 /PRNewswire/ -- Pharmacyclics, Inc.
- Note: This press release corresponds to abstracts 627 and 1998. SAN FRANCISCO, Dec. 8, 2014 /PRNewswire/ -- New IMBRUVICA(®) (ibrutinib) Phase II data announced by Pharmacyclics, Inc.
Company Outlines Plans for Phase III Registration Study San Diego, Dec. 8, 2014 /PRNewswire/ -- MEI Pharma, Inc.
- AbbVie Presents for the First Time Results from the Venetoclax Phase 2 Program in Acute Myelogenous Leukemia NORTH CHICAGO, Ill., Dec.
SAN FRANCISCO, Dec.
TG02 demonstrates ability to mobilize difficult-to-kill leukemic stem cells and render them vulnerable to chemotherapy. San Diego, California (PRWEB) December
- A volcanic mudflow.